Milliman

Seattle, Washington, United States

Healthcare InfrastructurePrivately Owned

Milliman is one of the world's largest independent actuarial and consulting firms, providing services across healthcare, employee benefits, investment, and insurance sectors. The company offers tailored solutions for various healthcare products and utilizes industry-leading data analytics to assist clients in controlling costs, expanding coverage, and managing regulatory complexities in healthcare.

Shareable draft

Check out Milliman on @MedStartr Today Milliman is one of the world's largest independent actuarial and consulting firms, providing services across healthcare, employee benefits, investment, and insurance sectors. The company offers tailored solutions for various healthcare products and utilizes industry-leading data analytics to assist clients in controlling costs, expanding coverage, and managing regulatory complexities in healthcare. #MentalBehavioralHealth #HealthcareInfrastructure #MedMo #MedStartrVentures

https://www.medstartr.ai/s/lub3wgeSXM8

Get Involved in Milliman

How We Help

Problem Statement

Milliman helps organizations navigate complex challenges in healthcare, employee benefits, insurance, and financial services, addressing issues like risk management, financial security, CMS payment models, and value-based care, aiming to improve system efficiency and outcomes.

Core Technology

Predictive health analytics, Milliman MedInsight, Milliman Health Waste Calculator, evidence-based clinical guidelines (in partnership with MCG Health).

Key Differentiators

industry-leading data analytics and solutions; AI-enabled analytics capabilities in healthcare; expertise in navigating payer, pharmacy benefit manager (PBM), and integrated delivery network (IDN) landscapes to develop strategies for product access

Clinical Focus

small molecule pharma; gene and cell therapies; rare diseases; biosimilars; medical devices; GLP-1 medications

Target Customers

Healthcare organizations, employers, insurance companies, financial services firms.

Product Stage

Mature

Company Info

Business Model: Consulting services, funded through operations and principal ownership (privately owned).
Founded: 1947
Website: www.milliman.com

Disease Areas

Mental Health

Technologies

Health ITClinical GuidelinesRisk ManagementActuarial SciencePredictive AnalyticsAnalytics & BIAI & Machine Learning

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Milliman?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.